saplin

Compare funds

Kotak Mid Cap vs DSP Midcap

Both are mid cap funds. Over the last 3 years Kotak Mid Cap returned 16.1% a year and DSP Midcap 13.5%, against a category median of 16.4%. Kotak Mid Cap costs 0.54% a year and DSP Midcap 0.83%. On the saplin Score Kotak Mid Cap rates 6.3 (Neutral) and DSP Midcap 6.0 (Neutral) within their category. 40.8% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Kotak Mid CapDSP MidcapCategory median
saplin Score (0–10)6.3 Neutral6.0 Neutral—
1-year return3.0%2.4%4.9%
3-year return, a year16.1%13.5%16.4%
5-year return, a year15.1%10.9%14.3%
Volatility (standard deviation)18.6%18.5%18.3%
Sharpe ratio0.570.470.62
Beta0.950.960.95
Upside capture989698
Downside capture929990
Expense ratio (Direct)0.54%0.83%0.94%
Fund size₹69,655 cr₹20,510 cr₹7,096 cr
Number of holdings746374
Top 10 holdings, share of fund28.4%29.6%27.5%
Portfolio P/E27.632.434.1
Lead managerAtul Bhole (3 yrs)Vinit Sambre (14 yrs)—
Launched30 Mar 200714 Nov 2006—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Kotak Mid Cap and DSP Midcap have 40.8% of their portfolios in the same stocks (32 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsKotak Mid CapDSP Midcap
Fortis Healthcare3.62%2.96%
IPCA Laboratories3.68%2.94%
The Federal Bank2.92%2.83%
Dixon Technologies (India)2.56%2.08%
Schaeffler India2.23%1.99%
Mphasis3.10%1.95%
Eternal1.64%1.91%
Aster DM Quality Care1.59%1.52%
Coromandel International1.50%2.29%
L&T Finance2.72%1.47%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.